Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a child, associated with a rotavirus infection: a case report
© Makis et al; licensee BioMed Central Ltd. 2010
Received: 1 March 2010
Accepted: 20 August 2010
Published: 20 August 2010
Sweet's syndrome characterized by fever, blood neutrophilia and inflammatory skin lesions, is rarely diagnosed in children. It presents in three clinical settings: classical Sweet's syndrome, usually after a respiratory tract infection; malignancy-associated, frequently related to acute myelogeneous leukemia; and drug-induced. We present, to the best of our knowledge, the first case of a rotavirus -infection-related Sweet's syndrome.
An 18-month-old boy of Hellenic origin was referred to us with diarrhea, fever, neutrophilia, typical skin lesions, asymmetrical hip arthritis and oropharyngeal involvement. A skin biopsy confirmed the diagnosis. Thorough screening did not reveal any underlying systemic illness, except for the confirmation of an overt rotavirus infection. The syndrome responded promptly upon corticosteroid administration; no recurrence was observed.
Besides describing the connection of Sweet's syndrome to a rotavirus infection, this case report is also a reminder that in a child presenting with a febrile papulo-nodular rash with neutrophilia Sweet's syndrome should be included in the differential.
Sweet's syndrome (acute febrile neutrophilic dermatosis) is characterized by a constellation of clinical symptoms and physical findings, which include fever, blood and tissue neutrophilia, leading to the development of tender, erythematous inflammatory skin lesions (papules, nodules, plaques), histopathologically characterized by the presence of abundant mature neutrophils . It presents in three clinical settings: 'classical' ('para-infectious') Sweet's syndrome, representing a hypersensitivity reaction preceding infection; malignancy-associated ('para-neoplastic') Sweet's syndrome (in children usually associated with acute myelogenous leukemia); and less frequently as an adverse drug reaction, sometimes in connection with certain underlying diseases (drug-induced Sweet's syndrome) . Irrespective of its cause, clinical and laboratory signs in Sweet's syndrome respond promptly to systemic corticosteroids. Spontaneous resolution is possible, although a persisting recurrent course over months is the rule .
Sweet's syndrome is rarely diagnosed in children . Here, on the occasion of a child with classical, "parainfectious" Sweet's syndrome we present, to the best of our knowledge for the first time in the accessible literature, the association of this syndrome to a rotavirus infection. The current report appends rotavirus to the list of infectious agents associated with Sweet's syndrome, thus expanding the pertinent diagnostic criteria .
Laboratory findings during the course of the syndrome
5th day of illness (admission to another hospital)
15th day of illness (admission to our hospital)
17th day of illness (initiation of prednisone)
20th day of illness
(3rd day on prednisone)
57th day of illness (termination of prednisone)
ESR (mm/1st hour)
Blood urea nitrogen (mg/dl)
Serum creatinine (mg/dl)
Serum potassium (meq/l)
Serum sodium (meq/l)
Antibiotic and antiviral medications were discontinued and intravenous prednisone (1 mg/kg body weight/24 h) was administered for 10 days with immediate cessation of the fever and gradual improvement of the skin lesions, the hip complaints and the laboratory findings (Table 1). Thereafter, prednisone was continued orally and tapered off slowly over a period of 40 days. After six months of follow-up no recurrence has been observed and the child is thriving.
We report on the case of an atypical vesicobullous variant of Sweet's syndrome in a child with a serologically documented preceding rotavirus infection. Although gastroenteritis often precedes an 'idiopathic' Sweet's syndrome, this is the first, to the best of our knowledge, documented case of an associated rotavirus infection and this syndrome. Given (a) the high prevalence of rotavirus infections, (b) the frequency of gastroenteritis as a concomitant disease of the Sweet's syndrome and (c) the wide suspicion in the literature that this syndrome is still under-diagnosed, this is a remarkable discrepancy, which calls for further exploration in future studies.
Sweet's syndrome was originally described in 1964 by Douglas Sweet as an 'acute febrile neutrophilic dermatosis' . Since then several cases have been reported in the literature, most of them in adults but also in children of all age groups . In children the syndrome is usually of the classic, 'para-infectious' subtype and in most cases follows a respiratory or a gastrointestinal infection. The most frequent nosologic entities that have been associated with this syndrome in children are shown in the Appendix.
Classical or idiopathic ('para-infectious') Sweet's syndrome is characterized by fever (higher than 38°C), blood leukocytosis and neutrophilia, which can precede the cutaneous manifestations for several days, characteristic skin lesions (tender erythematous papules or nodules which can develop into erythematous plaques with a characteristic papillomatous surface). Skin biopsy is the laboratory test that usually confirms the clinical diagnosis of Sweet's syndrome. Edema and a diffuse and perivascularly attenuated inflammatory infiltrate of mature neutrophils with neutrophil fragmentation in the upper dermis, yet without microscopical evidence of vasculitis are the hallmarks of the histopathological picture . The most often affected areas are the upper extremities, the face and the neck. Sometimes the lesions may resemble blisters, while less often, may mimic lesions of pyoderma gangrenosum (Figure 2). Another characteristic clinical feature is the Köbner phenomenon, that is, appearance of 'specific' skin lesions at sites of minor cutaneous trauma (biopsy, venipuncture, and so on.). Skin lesions in Sweet's syndrome usually resolve without scarring.
Apart from the involvement of the integument, as a result of an extensive, multiorganic, sterile neutrophilic inflammatory process other organic systems can be involved as well, as the hip involvement in our patient, probably the result of a sterile arthritis . Also, mucosal involvement is not unusual; it presents as edematous and aphthous lesions of the upper aero-digestive tract in the mouth and pharynx that can lead to airway obstruction, as happened to our patient too . Systemic symptoms that may coexist are headache, myalgias and arthralgias. The syndrome may resolve either automatically or after medication. Recurrence is considered as the most common complication and can take place in various time points. Quite typical is the immediate response to systemic corticosteroids, though after tapering off it recurs in at least one third of the cases. Corticosteroids (prednisone, 1 mg/kg body weight/24 h) are the treatment of choice, usually administered for 10 days and then tapered down slowly to avoid recurrence. However, in children the syndrome is considered more resistant to corticosteroids than in adults and sometimes protracted treatment for up to five months is required in order to avoid recurrences . Topical corticosteroids can be used in patients with localized lesions either as monotherapy or concurrently to systemic prednisone. Potassium iodide and colchicine have also been used with good results as monotherapies or in combination with corticosteroids, while indomethacin, clofazimine, cyclosporine and dapsone are considered as second-line modalities . In malignancy associated cases cure or remission of the underlying disease is followed by the clearance of the symptoms, while in drug induced cases spontaneous improvement is achieved by stopping the suspected medication.
The pathogenesis of Sweet's syndrome is still unknown. Its epidemiological characteristics and the related conditions (infections, malignancies, systemic autoimmune conditions, inflammatory bowel diseases and female predominance) classify this disorder among the diseases that relate to hypersensitivity reactions to bacterial, viral or tumor antigens or to drugs. Circulating autoantibodies, immune complexes and aberrant expression of different cytokines have all been postulated to explain the pathogenesis of this syndrome [12, 13]. According to the most recent view, the syndrome reflects a skin-confined or systemic disorder of the homeostasis of the cytokine network leading to abundance of pro-inflammatory cytokines in target tissues, especially of IL-1, G-CSF, GM-CSF and IFN-a. It is worth mentioning that rotavirus infections elicit an increased cytokine production in the intestinal epithelium, especially IL-8 and GM-CSF, which could explain the way by which this infection probably contributed to the induction of the Sweet's syndrome in our patient .
In conclusion, besides reporting the association between a rotavirus infection and Sweet's syndrome in a child, our case report is also a reminder that the differential diagnosis of a febrile child with a papulo-nodular rash and blood neutrophilia should always include Sweet's syndrome. In such cases thorough search for common infectious causes and complete examination for extracutaneous manifestations are mandatory and, after confirming the diagnosis, a step-by-step examination to rule out underlying malignancy is warranted. We think that our report of the correlation of the syndrome with rotavirus infection is important, as isolation of specific causative agents may help in revealing the pathophysiology of this probably underdiagnosed syndrome.
Diagnostic criteria for classical Sweet's syndrome (originally proposed by Su and Liu in 1986 and modified by von den Driesch in 1994)[4, 5]. For the establishment of the diagnosis of the syndrome two major and two of the four minor criteria are required. Major criteria: 1. Abrupt onset of tender erythematous plaques or nodules; 2. Dense neutrophilic infiltrate of the dermis without leukocytoclastic vasculitis. Minor criteria: 1. Fever of over 38°C; 2. Preceding respiratory or gastrointestinal infection or vaccination or association with an hematologic or another malignancy, inflammatory disease or pregnancy; 3. Three of the following four laboratory findings ESR > 20 mm/1st hour, leukocytes > 8.000/μl, neutrophils > 70%, positive CRP; 4. Excellent response to systemic corticosteroids or potassium iodide.
Conditions associated with Sweet's syndrome in children: upper respiratory tract illness, gastrontestinal infection, acute myelogenous leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, Fanconi's aplastic anaemia, congenital dyserythropoietic anaemia, aseptic meningitis, Behchet's disease, Takayasu arteriitis, systemic lupus erythematosus, ulcerative colitis, T-cell or humoral immunodeficiency, human immunodeficiency virus infection, chronic granulomatous disease, drugs (G-CSF, retinoic acid).
Written informed consent was obtained from the parents of the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Sweet RD: An acute febrile neutrophilic dermatosis. Br J Dermatol. 1964, 76: 349-356. 10.1111/j.1365-2133.1964.tb14541.x.View ArticlePubMedGoogle Scholar
- Cohen PR: Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007, 2: 34-10.1186/1750-1172-2-34.View ArticlePubMedPubMed CentralGoogle Scholar
- von den Driesch P: Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 31: 535-556. 10.1016/S0190-9622(94)70215-2. quiz 557-560
- Hospach T, von den Driesch P, Dannecker GE: Acute febrile neutrophilic dermatosis (Sweet's syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases. Eur J Pediatr. 2009, 168: 1-9. 10.1007/s00431-008-0812-0.View ArticlePubMedGoogle Scholar
- Su WP, Liu HN: Diagnostic criteria for Sweet's syndrome. Cutis. 1986, 37: 167-174.PubMedGoogle Scholar
- Halpern J, Salim A: Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol. 2009, 26: 452-457. 10.1111/j.1525-1470.2009.00952.x.View ArticlePubMedGoogle Scholar
- Farhi D, Wallach D: The neutrophilic dermatoses. Dermatol Nurs. 2008, 20: 274-276. 279-282PubMedGoogle Scholar
- Watanabe T, Nakashima K, Shindo M, Yoshida Y, Yamamoto O: Multiorgan involvement in Sweet's syndrome. Clin Exp Dermatol. 2009, 34: e343-344. 10.1111/j.1365-2230.2009.03290.x.View ArticlePubMedGoogle Scholar
- Bouw J, Kater AP, van Tongeren J, Schultz MJ: Upper-airway obstruction instigated by Sweet's syndrome. Med Sci Monit. 2007, 13: CS53-55.PubMedGoogle Scholar
- Cohen PR: Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009, 10: 301-312. 10.2165/11310730-000000000-00000.View ArticlePubMedGoogle Scholar
- Yi S, Bhate C, Schwartz RA: Sweet's syndrome: an update and review. G Ital Dermatol Venereol. 2009, 144: 603-612.PubMedGoogle Scholar
- Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, Muller CA, Waller HD: Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol. 1993, 84: 356-358. 10.1111/j.1365-2141.1993.tb03083.x.View ArticlePubMedGoogle Scholar
- Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY: Sweet's syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines?. J Am Acad Dermatol. 1998, 39: 940-943. 10.1016/S0190-9622(98)70266-X.View ArticlePubMedGoogle Scholar
- Ramig RF: Pathogenesis of intestinal and systemic rotavirus infection. JVirol. 2004, 78: 10213-10220. 10.1128/JVI.78.19.10213-10220.2004.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.